<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endoscopic cryotherapy is a new technique for ablation of <z:mp ids='MP_0000467'>esophageal dysplasia</z:mp> and <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Preliminary studies have shown it to be safe and effective for this indication </plain></SENT>
<SENT sid="2" pm="."><plain>The objective of this study is to characterize safety, tolerability, and efficacy of low-pressure liquid nitrogen endoscopic spray cryotherapy ablation in a large cohort across multiple study sites </plain></SENT>
<SENT sid="3" pm="."><plain>Parallel prospective treatment studies at four tertiary care academic medical centers in the U.S. assessed spray cryotherapy in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with or without <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, early stage <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, and severe squamous <z:mpath ids='MPATH_589'>dysplasia</z:mpath> who underwent cryotherapy ablation of the esophagus </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were contacted between 1 and 10 days after treatment to assess for side effects and complications of treatment </plain></SENT>
<SENT sid="5" pm="."><plain>The main outcome measurement was the incidence of serious adverse events and side effects from treatment </plain></SENT>
<SENT sid="6" pm="."><plain>Complete response for high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) (CR-HGD), <z:hpo ids='HP_0000001'>all</z:hpo> <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (CR-D), <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (CR-IM) and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (CR-C) were assessed in patients completing therapy during the study period </plain></SENT>
<SENT sid="7" pm="."><plain>A total of 77 patients were treated for Barrett's high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (58.4%), intramucosal <z:mp ids='MP_0002038'>carcinoma</z:mp> (16.9%), invasive <z:mp ids='MP_0002038'>carcinoma</z:mp> (13%), <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (9.1%), and severe squamous <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (2.6%) </plain></SENT>
<SENT sid="8" pm="."><plain>Twenty-two patients (28.6%) reported no side effects throughout treatment </plain></SENT>
<SENT sid="9" pm="."><plain>In 323 procedures, the most common complaint was <z:hpo ids='HP_0100749'>chest pain</z:hpo> (17.6%) followed by <z:hpo ids='HP_0002015'>dysphagia</z:hpo> (13.3%), odynophagia (12.1%), and sore throat (9.6%) </plain></SENT>
<SENT sid="10" pm="."><plain>The mean duration of any symptoms was 3.6 days </plain></SENT>
<SENT sid="11" pm="."><plain>No side effects were reported in 48% of the procedures (155/323) </plain></SENT>
<SENT sid="12" pm="."><plain>Symptoms did not correlate with age, gender, diagnosis, or to treatment early versus late in the patient's or site's experience </plain></SENT>
<SENT sid="13" pm="."><plain>Logit analysis showed that symptoms were greater in those with a Barrett's segment of 6 cm or longer </plain></SENT>
<SENT sid="14" pm="."><plain>Gastric <z:mpath ids='MPATH_81'>perforation</z:mpath> occurred in one patient with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain><z:hpo ids='HP_0002043'>Esophageal stricture</z:hpo> developed in three, <z:hpo ids='HP_0000001'>all</z:hpo> successfully treated with dilation </plain></SENT>
<SENT sid="16" pm="."><plain>In 17 HGD patients, cryotherapy produced CR-HGD, CR-D, and CR-IM of 94%, 88%, and 53%, respectively </plain></SENT>
<SENT sid="17" pm="."><plain>Complete regression of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and HGD was seen in <z:hpo ids='HP_0000001'>all</z:hpo> seven patients with intramucosal <z:mp ids='MP_0002038'>carcinoma</z:mp> or <z:e sem="disease" ids="C0278559" disease_type="Neoplastic Process" abbrv="">stage I esophageal cancer</z:e> </plain></SENT>
<SENT sid="18" pm="."><plain>Endoscopic spray cryotherapy ablation using low-pressure liquid nitrogen in the esophagus is safe, well-tolerated, and efficacious </plain></SENT>
</text></document>